Screening on Lung Cancer: Treatment…,
Pathare Anisha Dhondibhau
, Hole Shripali Bansi , Shivankar Anushka Bharat , Vaishnavi Dnyaneshwar Jadhav , Musale Divya Bapu
Lung cancer was the most common type of cancer diagnosed worldwide and also the main cause of cancer-related deaths among men globally in 2008.For women, it was the fourth most common cancer diagnosed and the second leading cause of cancer death. Lung cancer is one of the most common malignant cancers in most countries and is the biggest cause of death from cancer diseases around the world. Even though there have been continuous improvements in diagnosing and treating lung cancer, the survival rates for patients diagnosed with it are still not very good. Small-cell lung cancer (SCLC) makes up about 15% of all lung cancers and is known for growing quickly, spreading early, and having a poor prognosis. Exposure to the harmful chemicals in cigarettes is strongly connected to the development of SCLC. Only about one-third of patients are diagnosed with an early stage of the disease that can be treated with curative approaches. Genomic studies of SCLC have found that it has a high number of genetic mutations and widespread chromosomal changes, often involving the inactivation of the TP53 and RB1 tumor suppressor genes. The expression levels of key transcription factors have been used to classify different types of SCLC and to understand the variations within tumors. These variations are linked to how tumors grow, spread, and become resistant to treatment. Even though progress in treating SCLC has been limited, a better understanding of the disease's biology has uncovered new possible targets for treatment. The use of immune checkpoint inhibitors, a new treatment approach, has provided benefits for some patients, though only a small number experience long-term success. There is an urgent need to develop strategies that can better tailor treatments to those most likely to respond and to expand the benefits of effective immunity against cancer to more patients. These strategies are currently being explored.
"Screening on Lung Cancer: Treatment…,", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.10, Issue 9, page no.b611-b622, September-2025, Available :https://ijsdr.org/papers/IJSDR2509178.pdf
Volume 10
Issue 9,
September-2025
Pages : b611-b622
Paper Reg. ID: IJSDR_305029
Published Paper Id: IJSDR2509178
Downloads: 00042
Research Area: Pharmacy All
Country: Dist-Ahilyanagr,, Maharashtra, India
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
